Patents by Inventor Adrian Javier MUÑOZ

Adrian Javier MUÑOZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12171733
    Abstract: A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.
    Type: Grant
    Filed: January 26, 2024
    Date of Patent: December 24, 2024
    Assignee: Quimica Luar SRL
    Inventors: Luis Alberto Argañarás, Adrian Javier Muñoz, Roxana Valeria Alasino, Ariel Gustavo Garro, Dante Miguel Beltramo
  • Publication number: 20240325332
    Abstract: A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.
    Type: Application
    Filed: January 26, 2024
    Publication date: October 3, 2024
    Inventors: Luis Alberto Arganaras, Adrian Javier Munoz, Roxana Valeria Alasino, Ariel Gustavo Garro, Dante Miguel Beltramo
  • Patent number: 11925612
    Abstract: A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: March 12, 2024
    Assignee: Quimica Luar SRL
    Inventors: Luis Alberto Argañarás, Adrian Javier Muñoz, Roxana Valeria Alasino, Ariel Gustavo Garro, Dante Miguel Beltramo
  • Publication number: 20220040098
    Abstract: Disclosed is a method of treating a subject for a respiratory viral infection. The method comprises administering to the subject by inhalation an effective amount of a hypertonic saline solution comprising an ibuprofenate salt.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 10, 2022
    Inventors: Nicolas Martinez Rios, Adrian Javier Muñoz, Roxana Valeria Alasino, Ariel Gustavo Garro, Dante Miguel Beltramo, Galia Kalayan, Nestor Garcia
  • Publication number: 20210275476
    Abstract: A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.
    Type: Application
    Filed: March 12, 2021
    Publication date: September 9, 2021
    Inventors: Luis Alberto Argañarás, Adrian Javier Muñoz, Roxana Valeria Alasino, Ariel Gustavo Garro, Dante Miguel Beltramo
  • Patent number: 10973787
    Abstract: A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.
    Type: Grant
    Filed: October 4, 2016
    Date of Patent: April 13, 2021
    Assignee: Quimica Luar SRL
    Inventors: Luis Alberto Argañarás, Adrian Javier Muñoz, Roxana Valeria Alasino, Ariel Gustavo Garro, Dante Miguel Beltramo
  • Publication number: 20180296509
    Abstract: A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.
    Type: Application
    Filed: October 4, 2016
    Publication date: October 18, 2018
    Inventors: Luis Alberto ARGAÑARÁS, Adrian Javier MUÑOZ, Roxana Valeria ALASINO, Ariel Gustavo GARRO, Dante Miguel BELTRAMO